GENETICALLY ENGINEERED PRIMARY OLIGODENDROCYTES FOR TRANSPLANTATION-MEDIATED GENE DELIVERY IN THE CENTRAL NERVOUS SYSTEM

摘要

The present invention pertains to a method for transplanting genetically engineered primary cells into the central nervous system of a patient. The method comprises the steps of (a) isolating primary oligodendrocyte progenitor cells from the brain of a patient; (b) expanding the cells in vitro with mitogens; (c) genetically engineering the cells by introducing transgenes through an eukaryotic expression vector for DNA-mediated gene transfer into the cells; and (d) transplanting the genetically engineered primary cells into the brain of the patient.